Single-photon emission computed tomography (SPECT) is a nuclear imaging technique that uses radioactive tracers and a scanner to record data to produce two or three-dimensional images.
Wilmington, Delaware, United States, Transparency Market Research Inc. – Single-photon emission computed tomography (SPECT) is a nuclear imaging technique that uses radioactive tracers and a scanner to record data to produce two or three-dimensional images. SPECT has reportedly been combined with computed tomography (CT) and MRI scanners to provide detailed anatomical and metabolic information of a patient. SPECT systems have gained popularity globally due to usage in diagnosis of various diseases such as cardiac, brain, and cancer.
Read Report Overview – https://www.transparencymarketresearch.com/single-photon-emission-computed-tomography-systems-market.html
Moreover, several types of therapeutics radioisotopes, such as iodine-123, technetium-99m, xenon-133, thallium-201, and fluorine-18, are used along with the SPECT system for pain treatment and cell destruction procedure. Proper calibration and operation drive the high quality results of SPECT systems. However, new developments in computer technology and radiology medical devices using different modality are paving the way for earlier diagnosis and treatment of disease.
High prevalence of cardiovascular diseases, neurological diseases, and cancer, rise in patient awareness, surge in research and development initiatives, and increase in demand for diagnostic imaging devices such as MRI and X-ray devices are the major factors driving the single-photon emission computed tomography (SPECT) systems market. According to the WHO, cardiovascular diseases is one of the leading causes of death globally. In 2016, cardiovascular diseases accounted for 37% of the 16 million deaths under the age of 70 years due to non-communicable diseases.
Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43538
According to the WHO (2015), the number of new cancer cases is expected to rise by about 70% over the next two decades. Growth in technologies such as SPECT systems integrated with X-ray and computed tomography (CT) can fuel the overall diagnostic procedures for diseases such as cancer and neurological diseases. High cost of reagents, side effects of radiopharmaceutical, and sensitivity toward storage conditions are expected to hamper the growth of the single-photon emission computed tomography (SPECT) systems market.
The single-photon emission computed tomography (SPECT) systems market can be segmented based on tracer type, application, end-user, and region. In terms of tracer type, the market can be classified into technetium Tc-99m, iodine I-123, indium-111, gold Ag-198, iodine-125, iodine I-131, chromium CR-51, mercury Hg-197, mercury Hg-203, and others. Based on application, the global single-photon emission computed tomography (SPECT) systems market can be categorized into cardiology, oncology, neurology, and others. Cardiovascular is a rapidly growing segment because of increase in prevalence of cardiovascular diseases globally.
Request for ToC – https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=43538
According to the WHO, cardiovascular diseases accounted for 17.5 million deaths in 2012, representing 31% of all the global deaths. Of these, an estimated 7.4 million were due to coronary heart disease and 6.7 million were due to stroke. In terms of product type, the market can be bifurcated into hybrid SPECT system and standalone SPECT system. Based on end-user, the global single-photon emission computed tomography (SPECT) systems market can be divided into diagnostic laboratories, research institutes, hospitals, and others.
Geographically, the global single-photon emission computed tomography (SPECT) systems market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global market due to increase in number of heart patients, rise in cancer disease, and aging population.
Request for Report Methodology – https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=43538
Early-phase diagnosis and treatment of disease drives the medical devices market which in turn is expected to propel the single-photon emission computed tomography (SPECT) systems market in North America. Europe is the second largest market for single-photon emission computed tomography (SPECT) systems, the region has favorable government policies regarding health care infrastructure, favorable regulations on radiopharmaceutical products, presence of key players, and awareness programs about cancer and cardiovascular diseases.
The market in Asia Pacific is expected to grow at a rapid pace due to increase in population, changing lifestyle, rise in awareness among patients, and surge in per capita expenditure. Additionally, economic growth leading to improvement in health care infrastructure and increase in pharmaceutical distribution channels in developing countries such as India and China are likely to propel the single-photon emission computed tomography (SPECT) systems market in Asia Pacific.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=43538
Major players operating in the global single-photon emission computed tomography systems market include Mallinckrodt plc, GE Healthcare, Guerbet Group, Lantheus Medical Imaging, Inc., Daiichi Sankyo Company Limited, Eli Lilly and Company, Bayer AG, A Gamma Medica, Inc., Hologic, Inc., and Aytu BioScience, Inc.
More Trending Reports by Transparency Market Research –
Near-Infrared Fluorescence Imaging System Market: The global near-infrared fluorescence imaging system market is expected to cross the value of US$ 1.3 Bn by the end of 2031.
Syringes Market: The Europe syringes market expected to reach the value of US$ 6.9 Bn by the end of 2031. The global market is projected to expand at a CAGR of 5.3% from 2022 to 2031.
Audiological Devices Market: The global audiological devices market is anticipated to exceed US$ 16.9 Bn by 2031.
Breast Reconstruction Market: The global breast reconstruction market is anticipated to reach more than US$ 2.5 Bn by 2031.
Roadside Drug Testing Devices Market: The roadside drug testing devices market in the U.S. is anticipated to reach US$ 498.8 Mn by the end of 2031.
Retractable Needles Market: The global retractable needles market size is anticipated to exceed US$ 355.7 Mn by 2031.
Hearing Aids Market: The global hearing aids market is anticipated to reach US$ 15.6 Bn by the end of 2031. The global market is projected to expand at a CAGR of 6.3% from 2022 to 2031.
Eye Care Surgical Devices Market: The global eye care surgical devices market is anticipated to reach US$ 10.7 Bn by the end of 2031.
About Us
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com